BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29844320)

  • 1. Tumour-associated missense mutations in the dMi-2 ATPase alters nucleosome remodelling properties in a mutation-specific manner.
    Kovač K; Sauer A; Mačinković I; Awe S; Finkernagel F; Hoffmeister H; Fuchs A; Müller R; Rathke C; Längst G; Brehm A
    Nat Commun; 2018 May; 9(1):2112. PubMed ID: 29844320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerted action of the PHD, chromo and motor domains regulates the human chromatin remodelling ATPase CHD4.
    Morra R; Lee BM; Shaw H; Tuma R; Mancini EJ
    FEBS Lett; 2012 Jul; 586(16):2513-21. PubMed ID: 22749909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Significance of Nucleosome Remodeling and Deacetylase Complex Expression in Endometrial Carcinoma.
    Chu J; Lee SH; DO SI; Kim HS
    Anticancer Res; 2024 Apr; 44(4):1739-1750. PubMed ID: 38538000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHD4 mutations promote endometrial cancer stemness by activating TGF-beta signaling.
    Li Y; Liu Q; McGrail DJ; Dai H; Li K; Lin SY
    Am J Cancer Res; 2018; 8(5):903-914. PubMed ID: 29888111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks.
    Rubin AJ; Parker KR; Satpathy AT; Qi Y; Wu B; Ong AJ; Mumbach MR; Ji AL; Kim DS; Cho SW; Zarnegar BJ; Greenleaf WJ; Chang HY; Khavari PA
    Cell; 2019 Jan; 176(1-2):361-376.e17. PubMed ID: 30580963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosome-CHD4 chromatin remodeler structure maps human disease mutations.
    Farnung L; Ochmann M; Cramer P
    Elife; 2020 Jun; 9():. PubMed ID: 32543371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.
    Egan JB; Marks DL; Hogenson TL; Vrabel AM; Sigafoos AN; Tolosa EJ; Carr RM; Safgren SL; Hesles EE; Almada LL; Romecin-Duran PA; Iguchi E; Ala'Aldeen A; Kocher JA; Oliver GR; Prodduturi N; Mead DW; Hossain A; Huneke NE; Tagtow CM; Ailawadhi S; Ansell SM; Banck MS; Bryce AH; Carballido EM; Chanan-Khan AA; Curtis KK; Resnik E; Gawryletz CD; Go RS; Halfdanarson TR; Ho TH; Joseph RW; Kapoor P; Mansfield AS; Meurice N; Nageswara Rao AA; Nowakowski GS; Pardanani A; Parikh SA; Cheville JC; Feldman AL; Ramanathan RK; Robinson SI; Tibes R; Finnes HD; McCormick JB; McWilliams RR; Jatoi A; Patnaik MM; Silva AC; Wieben ED; McAllister TM; Rumilla KM; Kerr SE; Lazaridis KN; Farrugia G; Stewart AK; Clark KJ; Kennedy EJ; Klee EW; Borad MJ; Fernandez-Zapico ME
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 30761385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The landscape of somatic mutation in sporadic Chinese colorectal cancer.
    Liu Z; Yang C; Li X; Luo W; Roy B; Xiong T; Zhang X; Yang H; Wang J; Ye Z; Chen Y; Song J; Ma S; Zhou Y; Yang M; Fang X; Du J
    Oncotarget; 2018 Jun; 9(44):27412-27422. PubMed ID: 29937994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy-driven genome regulation by ATP-dependent chromatin remodellers.
    Eustermann S; Patel AB; Hopfner KP; He Y; Korber P
    Nat Rev Mol Cell Biol; 2024 Apr; 25(4):309-332. PubMed ID: 38081975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromodomain helicase DNA binding protein 4 in cell fate decisions.
    Laureano A; Kim J; Martinez E; Kwan KY
    Hear Res; 2023 Sep; 436():108813. PubMed ID: 37329862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of auxiliary domains in modulating CHD4 activity suggests mechanistic commonality between enzyme families.
    Zhong Y; Moghaddas Sani H; Paudel BP; Low JKK; Silva APG; Mueller S; Deshpande C; Panjikar S; Reid XJ; Bedward MJ; van Oijen AM; Mackay JP
    Nat Commun; 2022 Dec; 13(1):7524. PubMed ID: 36473839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers.
    Reske JJ; Wilson MR; Armistead B; Harkins S; Perez C; Hrit J; Adams M; Rothbart SB; Missmer SA; Fazleabas AT; Chandler RL
    BMC Biol; 2022 Sep; 20(1):209. PubMed ID: 36153585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.
    Kumar A; Lyu Y; Yanagihashi Y; Chantarasrivong C; Majerciak V; Salemi M; Wang KH; Inagaki T; Chuang F; Davis RR; Tepper CG; Nakano K; Izumiya C; Shimoda M; Nakajima KI; Merleev A; Zheng ZM; Campbell M; Izumiya Y
    Cell Rep; 2022 May; 39(6):110788. PubMed ID: 35545047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.
    Hagman JR; Arends T; Laborda C; Knapp JR; Harmacek L; O'Connor BP
    Immunol Rev; 2022 Jan; 305(1):29-42. PubMed ID: 34927255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway.
    Guo L; Luo X; Yang P; Zhang Y; Huang J; Wang H; Guo Y; Huang W; Chen Z; Wang S; Wang J; Lei J; Xiang S; Liu Y
    Front Pharmacol; 2021; 12():723729. PubMed ID: 34776951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease.
    Alendar A; Berns A
    Genes Dev; 2021 Nov; 35(21-22):1403-1430. PubMed ID: 34725129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sophisticated Conversations between Chromatin and Chromatin Remodelers, and Dissonances in Cancer.
    Clapier CR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer.
    Novillo A; Fernández-Santander A; Gaibar M; Galán M; Romero-Lorca A; El Abdellaoui-Soussi F; Gómez-Del Arco P
    Front Oncol; 2021; 11():633233. PubMed ID: 33981601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective.
    Mossink B; Negwer M; Schubert D; Nadif Kasri N
    Cell Mol Life Sci; 2021 Mar; 78(6):2517-2563. PubMed ID: 33263776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential activation of transcriptional repressors promotes progenitor commitment by silencing stem cell identity genes.
    Rives-Quinto N; Komori H; Ostgaard CM; Janssens DH; Kondo S; Dai Q; Moore AW; Lee CY
    Elife; 2020 Nov; 9():. PubMed ID: 33241994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.